MENU

Ohio State biotech spinoff targeting MD raises $182M in IPO

An Ohio State University spinoff developing treatments for "undruggable" diseases has raised $181.5 million in an IPO.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
TOP
Email a Story